Product Information
MONTELUKAST SOD 4 MG GRANULES is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.8126 per EA under NDC 27241001531. Its NADAC has been published 563 times since Dec 23, 2015.
FDA first approved this application on Jul 31, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241001531
Classification
Generic
Dosage Form
GRANULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MONTELUKAST SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203438FDA Approved
7/31/2015
TE Code
AB
On Market Since
8/13/2015
Pharmacological Classes
Price Statistics
The NADAC for MONTELUKAST SOD 4 MG GRANULES has been published 563 times since Dec 23, 2015, and over the history we have for it it has declined 79.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8126 per EA |
|---|---|
| All-time high | $4.1135 (Mar 16, 2016) |
| All-time low | $0.8061 (May 22, 2024) |
| 52-week high | $1.1226 |
| 52-week low | $0.8126 |
| Median price | $1.4634 |
| Average price | $1.8612 |
| Largest weekly change | +39.7% (Mar 20, 2024) |
| Weeks tracked | 563 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MONTELUKAST SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MONTELUKAST SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukotriene Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MONTELUKAST SOD 4 MG GRANULES?
The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 4 MG GRANULES, manufactured by Ajanta Pharma USA Inc., is $0.8126 per EA (NDC 27241001531), effective Sep 30, 2026.
How has the price of MONTELUKAST SOD 4 MG GRANULES changed over time?
Over the history we have for it, the NADAC for MONTELUKAST SOD 4 MG GRANULES has declined 79.9%. It has been tracked across 563 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 4 MG GRANULES?
Since Dec 23, 2015, the NADAC for MONTELUKAST SOD 4 MG GRANULES has ranged from a low of $0.8061 (May 22, 2024) to a high of $4.1135 (Mar 16, 2016), with a median of $1.4634 per EA.
Are there cheaper alternatives to MONTELUKAST SOD 4 MG GRANULES?
No other NADAC-published product currently shares the active ingredient and strength of MONTELUKAST SOD 4 MG GRANULES in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MONTELUKAST SOD 4 MG GRANULES?
MONTELUKAST SOD 4 MG GRANULES (NDC 27241001531) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.